Phibro Animal Health Sees Limited Impact From New Brazilian Antimicrobial Rules
MT Newswires Live
Apr 28
Phibro Animal Health (PAHC) expects limited impact on its fiscal 2026 results following the implementation of new rules prohibiting certain antimicrobial feed additives in Brazil, the company said Monday.
The country has banned the import, manufacture, marketing, and use of antimicrobial feed additives that are also important in human or veterinary medicine, including virginiamycin and bacitracin. The regulation will take effect after a 180-day transition period.
The company said it is in the final stages of regulatory review and approval for virginiamycin for therapeutic use in cattle and broiler chickens, while its bacitracin product already has therapeutic claims in Brazil.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.